PRESS RELEASES

July 16, 2014

Strides Arcolab makes strategic investment in Oncobiologics more >

06/26/2014

Liomont and Oncobiologics partner to launch Biosimilars in Mexico more >

June 12, 2014

Oncobiologics launches Phase I Clinical Trial for ONS-3010 Biosimilar version of Humira® more >

June 2, 2014

Ipca and Oncobiologics Create Strategic Biosimilars Partnership more >

5/23/2014

Oncobiologics CEO named finalist in EY Entrepreneur Of The Year 2014 New Jersey program more >

August 6, 2013

Oncobiologics and inVentiv Health Form Strategic Biosimilars Partnership more >

May 8, 2013

Huahai and Oncobiologics Create Broad Biosimilars Partnership more >

July, 30, 2012

Oncobiologics announces Agreement to utilize XOMA's Fully Human Antibody Libraries for Discovery Platform more >

May 24, 2012

Oncobiologics Fills Key Leadership Positions and Names Scientific Advisory Board more >

December 2, 2011

Oncobiologics, Inc. receives NJSBDC Small Business Growth Success Award more >

October 14, 2011

Grand Opening & Ribbon Cutting Event more >

October 12, 2011

Oncobiologics Appoints Scott Canute, Former President of Eli Lilly and Genzyme, to its Board of Directors more >

September 26, 2011

Oncobiologics, Inc. grand opening event to be held October 14, 2011 more >

August 22, 2011

Oncobiologics, Inc. and Fox Chase Cancer Center Announce Co-Development of a Novel Cancer Therapy Platform more >